Yuxiong Jiang

发表

ERO1L promotes NSCLC development by modulating cell cycle‐related molecules

Xiujuan Shi, Jue Li, Jiawen Wu, 2020, Cell biology international.

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma

Xiujuan Shi, Yuxiong Jiang, W. Gu, 2022, Frontiers in Immunology.

Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment

Peng Liu, Fang Wang, Bing Tao, 2022, Frontiers in Pharmacology.

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Qian Yu, Youdong Chen, Yuling Shi, 2023, BioDrugs.

Comprehensive Analyses of the Expression, Genetic Alteration, Prognosis Significance, and Interaction Networks of m6A Regulators Across Human Cancers

Xiujuan Shi, Jieping Zhang, Jue Li, 2021, Frontiers in Genetics.

Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway

Xiujuan Shi, Jieping Zhang, Weibing Dong, 2022, Molecular Biology Reports.

Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.

Xiujuan Shi, Jieping Zhang, Yuxiong Jiang, 2021, International immunopharmacology.

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway

Xiujuan Shi, Xianling Guo, Qing Xu, 2023, Cell & Bioscience.

Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway

Xiujuan Shi, Jieping Zhang, Weibing Dong, 2022, Molecular Biology Reports.